Chinese Journal of Tissue Engineering Research ›› 2010, Vol. 14 ›› Issue (32): 6036-6039.doi: 10.3969/j.issn.1673-8225.2010.32.032

Previous Articles     Next Articles

Research progress addressing muscle-derived stem cells injection for treatment of stress urinary incontinence

Tu You-bing, Li Ai-bin   

  1. Department of Reproductive Center, Renmin Hospital, Wuhan University, Wuhan  430060, Hubei Province, China
  • Online:2010-08-06 Published:2010-08-06
  • Contact: Li Ai-bin, Doctor, Master’s supervisor, Chief physician, Professor, Department of Reproductive Center, Renmin Hospital, Wuhan University, Wuhan 430060, Hubei Province, China liaibin67@163.com
  • About author:Tu You-bing★, Master, Department of Reproductive Center, Renmin Hospital, Wuhan University, Wuhan 430060, Hubei Province, China tybing83@163.com
  • Supported by:

     the National Natural Science Foundation of China, No. 30870638*; the Natural Science Foundation of Hubei Province, No. 2006ABA223*

Abstract:

BACKGROUND: Injection therapy for stress urinary incontinence is a minimally invasive means of treatment, but because of previous vaccination materials restriction, there are many complications, with poor long-term effects. It is significant to search new injection materials.
OBJECTIVE: To retrospectively analyze the research of stress urinary incontinence using muscle-derived stem cells.
METHODS: The first author retrieved PubMed database, Springer database and China National Knowledge Infrastructure for articles concerning muscle-derived stem cells for treatment of stress urinary incontinence published from 2003 to 2010. The key words were “stress urinary incontinence, muscle-derived stem cell”. A total of 40 articles were retrieved primarily by computer, and 24 articles were finally included for review according to inclusion criteria.
RESULTS AND CONCLUSION: Treatment method of stress urinary incontinence mainly included non-surgery therapy and surgery therapy. The surgery treatment exists many complications, even risk for overcorrect. However, the injection therapy, as a non-surgery therapy, was simple to operate, could be accepted by patients. Muscle-derived stem cells following injection have many advantages, such as long-term survival, not easy to broken down, not easy to move, low immunogenicity, and will have a bright prospect in the future.

CLC Number: